DK254390D0 - Immunoafproevning til paavisning, kvantificering eller klassificering af ras-proteiner i legemsfluida, -vaev eller -celler - Google Patents

Immunoafproevning til paavisning, kvantificering eller klassificering af ras-proteiner i legemsfluida, -vaev eller -celler

Info

Publication number
DK254390D0
DK254390D0 DK254390A DK254390A DK254390D0 DK 254390 D0 DK254390 D0 DK 254390D0 DK 254390 A DK254390 A DK 254390A DK 254390 A DK254390 A DK 254390A DK 254390 D0 DK254390 D0 DK 254390D0
Authority
DK
Denmark
Prior art keywords
detection
cells
quantification
classification
tissue
Prior art date
Application number
DK254390A
Other languages
English (en)
Other versions
DK254390A (da
Inventor
Walter Patrick Carney
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK254390D0 publication Critical patent/DK254390D0/da
Publication of DK254390A publication Critical patent/DK254390A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK254390A 1988-04-22 1990-10-22 Immunoafproevning til paavisning, kvantificering eller klassificering af ras-proteiner i legemsfluida, -vaev eller -celler DK254390A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18558288A 1988-04-22 1988-04-22
US33482389A 1989-04-11 1989-04-11
PCT/US1989/001615 WO1989010565A1 (en) 1988-04-22 1989-04-20 Detection, quantitation and classification of ras proteins in body fluids and tissues

Publications (2)

Publication Number Publication Date
DK254390D0 true DK254390D0 (da) 1990-10-22
DK254390A DK254390A (da) 1990-12-21

Family

ID=26881267

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254390A DK254390A (da) 1988-04-22 1990-10-22 Immunoafproevning til paavisning, kvantificering eller klassificering af ras-proteiner i legemsfluida, -vaev eller -celler

Country Status (9)

Country Link
EP (2) EP0411018B1 (da)
JP (1) JPH0816679B2 (da)
AT (2) ATE258686T1 (da)
AU (1) AU634961B2 (da)
CA (1) CA1340368C (da)
DE (2) DE68929511T2 (da)
DK (1) DK254390A (da)
FI (1) FI905189A7 (da)
WO (1) WO1989010565A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
US6087188A (en) * 1992-11-13 2000-07-11 Alk A/S Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand
AU5587998A (en) * 1996-11-15 1998-06-03 Cornell Research Foundation Inc. Activated ras interaction assay
WO2007002505A1 (en) * 2005-06-23 2007-01-04 Bayer Healthcare Llc Quantitative assays for ras p21 in body fluids
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5769417B2 (ja) * 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 腫瘍細胞由来微小胞

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228237A (en) * 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
JPS5837713B2 (ja) 1978-12-01 1983-08-18 富士通株式会社 半導体レ−ザ−装置の製造方法
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
US4535058A (en) 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US4504585A (en) * 1982-04-05 1985-03-12 Aalto Scientific, Ltd. Affinity immunoassay system
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
CA1219232A (en) 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US4725550A (en) * 1984-01-19 1988-02-16 Research Foundation Of State University Of New York Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma
US4762706A (en) * 1984-10-17 1988-08-09 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
JPS6185327A (ja) * 1984-09-19 1986-04-30 シタス　コーポレイシヨン 発癌遺伝子生成物に対する抗体
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
GB8501563D0 (en) * 1985-01-22 1985-02-20 Kodak Ltd Uv-absorbing polymers
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
CA1296660C (en) * 1985-01-29 1992-03-03 Walter P. Carney Monoclonal antibody against a ras oncogene p21 related dodecapeptide
EP0428518A4 (en) * 1988-04-22 1992-02-19 E.I. Du Pont De Nemours And Company Monoclonal antibodies specific for the harvey, kirsten and n ras proteins and their use as diagnostic reagents
TWI228804B (en) 2003-07-02 2005-03-01 Lite On Semiconductor Corp Chip package substrate having flexible printed circuit board and method for fabricating the same

Also Published As

Publication number Publication date
DE68928106D1 (de) 1997-07-10
DK254390A (da) 1990-12-21
EP0411018A4 (en) 1991-08-21
WO1989010565A1 (en) 1989-11-02
EP0411018A1 (en) 1991-02-06
JPH03505250A (ja) 1991-11-14
ATE258686T1 (de) 2004-02-15
CA1340368C (en) 1999-02-02
AU3447989A (en) 1989-11-24
FI905189A0 (fi) 1990-10-22
JPH0816679B2 (ja) 1996-02-21
DE68929511D1 (de) 2004-03-04
EP0767381B1 (en) 2004-01-28
EP0411018B1 (en) 1997-06-04
DE68929511T2 (de) 2004-11-18
ATE154134T1 (de) 1997-06-15
AU634961B2 (en) 1993-03-11
DE68928106T2 (de) 1997-12-04
EP0767381A1 (en) 1997-04-09
FI905189A7 (fi) 1990-10-22

Similar Documents

Publication Publication Date Title
CY1115366T1 (el) Δεικτες ογκου
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
FI845061L (fi) Foerfarande och produkter foer paovisande av humant t-celleukemivirus.
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
EP1364063A4 (en) DETECTION OF HERPEX-SIMPLEX-VIRUS
WO1995016919A3 (en) Methods and compositions for the detection of colon cancers
FI901916A7 (fi) Diagnostinen testipakkaus, alukekoostumus, ja näiden käyttö nukleiinihappojen replikaatioon tai havaitsemiseen
ZA854700B (en) In vitro detection of gastrointestinal cancer
RU2218178C2 (ru) Антитела против фосфорилированного vasp (стимулированного вазодилататором фосфопротеина), гибридомные клетки для их получения и их применение
EP1537415A4 (en) METHOD FOR DIAGNOSIS OF NUTRITIONAL CANCER
DK254390D0 (da) Immunoafproevning til paavisning, kvantificering eller klassificering af ras-proteiner i legemsfluida, -vaev eller -celler
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
NO953770L (no) Analysemetode
DK0569367T3 (da) Detektering af syndecanindhold i biologiske materialer, såsom væv og kropsvæsker, som indikationer på maligne transformatio
KR970011852A (ko) 자가면역 질환의 진단 방법
Kunstýř et al. Humoral antibody response of rabbits to experimental infection with Encephalitozoon cuniculi
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE118018T1 (de) Menschliches macrophageentzündungsprotein-2-beta.
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
GR1000033B (el) Δοκιμασια για την ανιχνευση αντιγονων ηπατιτιδας και αντισωματων aids.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
BR0209172A (pt) Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método
FI990380A0 (fi) Diagnostinen ja seulontamenetelmä
DE60237406D1 (de) Aus einem Neuroblastom isolierte Nukleinsäuren
Okabe et al. Immunoinhibitory determination of CK-MM subbands by monoclonal antibody

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment